Difference between revisions of "CMV colitis"

(Background)
 
(8 intermediate revisions by 4 users not shown)
Line 5: Line 5:
 
*Severe systemic illness is found in immunosuppressed hosts
 
*Severe systemic illness is found in immunosuppressed hosts
  
==Clinical Presentation==
+
==Clinical Features==
 +
*[[Fever]]
 +
*Anorexia
 +
*Malaise
 +
*[[Abdominal pain]], Abdominal distention, [[constipation]]
 +
*[[Nausea/vomiting]]
 +
*Chronic watery [[diarrhea]]
 +
*[[rectal bleeding|Bloody diarrhea]]
 +
*Worsening symptoms of [[inflammatory bowel disease]]
 +
*Weight loss
 +
*[[Dehydration]]
  
 
==Differential Diagnosis==
 
==Differential Diagnosis==
 +
{{Colitis DDX}}
  
==Diagnosis==
+
{{CMV types}}
 +
 
 +
==Evaluation==
  
 
==Management==
 
==Management==
 +
{{CMV colitis treatment}}
  
 
==Disposition==
 
==Disposition==
{{CMV colitis treatment}}
 
 
==See Also==
 
==See Also==
 
*[[Cytomegalovirus (CMV) infection]]
 
*[[Cytomegalovirus (CMV) infection]]

Latest revision as of 20:03, 29 September 2019

Background

  • CMV is part of the Herpesviridae family
  • 50-80% of the world's population is seropositive for CMV
  • Causes a mild or undetectable infection in immunocompetent hosts
  • Severe systemic illness is found in immunosuppressed hosts

Clinical Features

Differential Diagnosis

Colitis

CMV Diseases

Evaluation

Management

  • Ganciclovir 5mg/kg IV q12hrs x 21 days (or until resolution of symptoms)
  • Foscarnet 90mg/kg IV q12hrs daily x 21 days (or until resolution of symptoms)

Disposition

See Also

External Links

References